Clot-busting drug set to save NHS money

Giving a new clot-busting drug to people who have had a stroke could help save the NHS millions of pounds. The National Institute for Health and Care Excellence (NICE) has published its final guidance recommending tenecteplase (also called Metalyse and made by Boehringer Ingelheim) as an option for treating acute ischaemic stroke in adults. The clinical evidence showed tenecteplase was as effective as alteplase, which NICE also recommends, in breaking up blood clots or preventing new blood clots from forming (thrombolytic treatment) after an acute ischaemic stroke.

Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Weekly Newsletter

Daily news updates

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.